EXOZ Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
3.0M
+23.8%
2.4M
-11.4%
2.7M
+6.9%
2.5M
-1.0%
2.5M
R&D
1.4M
+29.3%
1.1M
+0.8%
1.1M
-8.6%
1.2M
+44.0%
844.8K
SG&A
1.5M
+18.8%
1.3M
-20.0%
1.6M
+21.3%
1.3M
-23.4%
1.7M
Operating Income
-2953890
-23.8%
-2386974
+11.4%
-2695490
-6.9%
-2522208
+1.0%
-2548045
EBITDA
-2864949
-23.2%
-2324819
+11.8%
-2634591
-6.9%
-2463660
-0.1%
-2462334
Net Income
-2878614
-21.4%
-2370247
+10.7%
-2655036
-16.1%
-2286991
+3.1%
-2360286
EPS (Basic)
$-0.33
-17.9%
$-0.28
+12.5%
$-0.32
-18.5%
$-0.27
+3.6%
$-0.28
EPS (Diluted)
$-0.33
-17.9%
$-0.28
+12.5%
$-0.32
-18.5%
$-0.27
+3.6%
$-0.28
Shares (Diluted)
8.7M
+2.4%
8.5M
+0.8%
8.4M
+0.1%
8.4M
+0.1%
8.4M
eXoZymes (EXOZ) โ€” Financials